IP Group has committed a total of $6.6m to a series A round for Enterprise Therapeutics, which had previously attracted capital from Touchstone Innovations.

John Flavin joined University of Chicago in 2013 to head its commercialisation arm and innovation hub Polsky Center, but will now become chief financial officer at Endotronix.

Nielsen Ventures was among the participants as the nutritional data platform completed a series A round to boost its overall funding to $10m.

Harel Insurance and Finance, which helped form cancer therapy developer Ayala Pharmaceuticals in November, is among the investors.

Medical analytics platform developer Aetion raised $36.4m in an Amgen Ventures-backed round that took its total funding to $50m.

Merck Global Health Innovation Fund, Microsoft Ventures, Zaffre Investments and Echo Health Ventures invested in a round that valued Livongo at $800m.

Inova Health and BlueCross BlueShield Venture Partners contributed to a series B round that will fund the strengthening of the startup's services and technology.

Partially based on research at Duke University, Camras Vision is working on a treatment for refractory glaucoma.